ArticleBritish journal of haematology2026

Response alone does not define optimal bridging before brexucabtagene autoleucel in mantle cell lymphoma.

Mingxin Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.